Induction immunosuppression for combined heart-lung transplantation. 2016

Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. hayes.705@osu.edu.

Research on induction immunosuppression in patients undergoing combined heart-lung transplantation (HLTx) is limited. The United Network for Organ Sharing database was queried from 2000 to 2013 to examine the influence of induction immunosuppression for combined HLTx in adult (≥18 years) and adolescent (≥12 and <18 years) recipients. Of 394 eligible combined HLTx cases (361 adults, 33 adolescents), 384 were included in univariate Cox analysis and 116 in the multivariate Cox model. Univariate analysis demonstrated no differences in survival by induction medication and no difference among the most common maintenance immunosuppression regimens. Adjusting for use of corticosteroids, multivariate analysis demonstrated no benefit of basiliximab (HR=3.582; 95% CI: 0.966, 13.279; P=.056), thymoglobulin/antilymphocyte globulin (ALG)/antithymocyte globulin (ATG) (HR=0.808; 95% CI: 0.134, 4.888; P=.817), alemtuzumab (HR=0.369; 95% CI: 0.087, 1.563; P=.176), or other induction medications (HR=1.511; 95% CI: 0.146, 15.610; P=.729), compared to no induction medication, with respect to mortality hazard post-HLTx. There were also no differences in treated acute rejection episodes by type of induction immunosuppression. Induction immunosuppression with contemporary agents does not improve survival after combined HLTx.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
January 1999, The Annals of thoracic surgery,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
December 2009, Progress in transplantation (Aliso Viejo, Calif.),
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
January 2010, Clinical transplantation,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
July 2022, Indian journal of thoracic and cardiovascular surgery,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
October 2008, Transplantation proceedings,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
December 1997, Medizinische Klinik (Munich, Germany : 1983),
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
November 2000, Transplantation proceedings,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
January 2004, Seminars in thoracic and cardiovascular surgery,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
January 2009, Proceedings of the American Thoracic Society,
Don Hayes, and Patrick I McConnell, and Andrew R Yates, and Joseph D Tobias, and Mark Galantowicz, and Heidi M Mansour, and Dmitry Tumin
January 2009, Frontiers in bioscience (Landmark edition),
Copied contents to your clipboard!